Key result
Left ventricular hypertrophy is a strong predictor of cardiovascular morbidity and mortality in the dialysis population, though few studies exist on its prevalence and predictors in chronic kidney disease.
Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) is defined as the presence of kidney damage or decreased renal function for at least three months, and is associated with high prevalence of cardiovascular complications. While left ventricular hypertrophy (LVH) is the single strongest predictor of cardiovascular morbidity and mortality in dialysis population, very few studies are available on LVH prevalence and predictors in CKD.
No takes yet. Share an insight, caveat, or question.
Ernesto Paoletti (2004) conducted a review in Chronic kidney disease. Left ventricular hypertrophy is a strong predictor of cardiovascular morbidity and mortality in the dialysis population, though few studies exist on its prevalence and predictors in chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: